APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Inactive Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Swine Inactive Vaccine Market Outlook and Growth Opportunities 2026

31 December 2025193 pages

Choose your research edition.

Industry ResearchSwine Inactive Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Inactive Vaccine Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Swine Inactive Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Inactive Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Inactive Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Swine Inactive Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Inactive Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Swine Inactive Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Swine Inactive Vaccine market include Zhongmu Industry, Wuhan Keqian Biology, Shenzhen BIOCBD Biotechnology, Shenlian Biomedical, Qindao Lijian Bio-Tech, Jinyu Biotechnology, Harbin Pharmaceutical Group Bio-vaccine, DHN and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Inactive Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Inactive Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Inactive Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Inactive Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Inactive Vaccine Segment by Company

Zhongmu Industry

Wuhan Keqian Biology

Shenzhen BIOCBD Biotechnology

Shenlian Biomedical

Qindao Lijian Bio-Tech

Jinyu Biotechnology

Harbin Pharmaceutical Group Bio-vaccine

DHN

Boehringer Ingelheim

Swine Inactive Vaccine Segment by Type

Haemophilus Parasuis Vaccine

Porcine Circovirus Type 2 Vaccine

Mycoplasma Hyopneumoniae Bacterin Vaccine

Others

Swine Inactive Vaccine Segment by Application

Breeding Farm

Veterinary Clinic

Swine Inactive Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Swine Inactive Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Swine Inactive Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Swine Inactive Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Swine Inactive Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Inactive Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Inactive Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Inactive Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Inactive Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Swine Inactive Vaccine industry.

Chapter 3: Detailed analysis of Swine Inactive Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Swine Inactive Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Swine Inactive Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Swine Inactive Vaccine Industry Trends Table 2. Swine Inactive Vaccine Industry Drivers Table 3. Swine Inactive Vaccine Industry Opportunities and Challenges Table 4. Swine Inactive Vaccine Industry Restraints Table 5. Global Swine Inactive Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Swine Inactive Vaccine Revenue Share by Company (2021-2026) Table 7. Global Swine Inactive Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Swine Inactive Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Swine Inactive Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Swine Inactive Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Swine Inactive Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Swine Inactive Vaccine Company, Product Type & Application Table 13. Global Swine Inactive Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Inactive Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Haemophilus Parasuis Vaccine Table 18. Significant Companies of Porcine Circovirus Type 2 Vaccine Table 19. Significant Companies of Mycoplasma Hyopneumoniae Bacterin Vaccine Table 20. Significant Companies of Others Table 21. Global Swine Inactive Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Swine Inactive Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Swine Inactive Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Swine Inactive Vaccine Sales Volume Share by Type (2021-2026) Table 25. Global Swine Inactive Vaccine Sales Volume Share by Type (2027-2032) Table 26. Global Swine Inactive Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Swine Inactive Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Swine Inactive Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Swine Inactive Vaccine Sales Value Share by Type (2021-2026) Table 30. Global Swine Inactive Vaccine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Breeding Farm Table 32. Significant Companies of Veterinary Clinic Table 33. Global Swine Inactive Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Swine Inactive Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Swine Inactive Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Swine Inactive Vaccine Sales Volume Share by Application (2021-2026) Table 37. Global Swine Inactive Vaccine Sales Volume Share by Application (2027-2032) Table 38. Global Swine Inactive Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Swine Inactive Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Swine Inactive Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Swine Inactive Vaccine Sales Value Share by Application (2021-2026) Table 42. Global Swine Inactive Vaccine Sales Value Share by Application (2027-2032) Table 43. Global Swine Inactive Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Swine Inactive Vaccine Sales by Region (2021-2026) & (K Units) Table 45. Global Swine Inactive Vaccine Sales Market Share by Region (2021-2026) Table 46. Global Swine Inactive Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Swine Inactive Vaccine Sales Market Share by Region (2027-2032) Table 48. Global Swine Inactive Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Swine Inactive Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Swine Inactive Vaccine Sales Value Share by Region (2021-2026) Table 51. Global Swine Inactive Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Swine Inactive Vaccine Sales Value Share by Region (2027-2032) Table 53. Global Swine Inactive Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Swine Inactive Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Swine Inactive Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Swine Inactive Vaccine Sales by Country (2021-2026) & (K Units) Table 58. Global Swine Inactive Vaccine Sales Market Share by Country (2021-2026) Table 59. Global Swine Inactive Vaccine Sales by Country (2027-2032) & (K Units) Table 60. Global Swine Inactive Vaccine Sales Market Share by Country (2027-2032) Table 61. Global Swine Inactive Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Swine Inactive Vaccine Sales Value Market Share by Country (2021-2026) Table 63. Global Swine Inactive Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Swine Inactive Vaccine Sales Value Market Share by Country (2027-2032) Table 65. Zhongmu Industry Company Information Table 66. Zhongmu Industry Business Overview Table 67. Zhongmu Industry Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Zhongmu Industry Swine Inactive Vaccine Product Portfolio Table 69. Zhongmu Industry Recent Development Table 70. Wuhan Keqian Biology Company Information Table 71. Wuhan Keqian Biology Business Overview Table 72. Wuhan Keqian Biology Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio Table 74. Wuhan Keqian Biology Recent Development Table 75. Shenzhen BIOCBD Biotechnology Company Information Table 76. Shenzhen BIOCBD Biotechnology Business Overview Table 77. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio Table 79. Shenzhen BIOCBD Biotechnology Recent Development Table 80. Shenlian Biomedical Company Information Table 81. Shenlian Biomedical Business Overview Table 82. Shenlian Biomedical Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Shenlian Biomedical Swine Inactive Vaccine Product Portfolio Table 84. Shenlian Biomedical Recent Development Table 85. Qindao Lijian Bio-Tech Company Information Table 86. Qindao Lijian Bio-Tech Business Overview Table 87. Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio Table 89. Qindao Lijian Bio-Tech Recent Development Table 90. Jinyu Biotechnology Company Information Table 91. Jinyu Biotechnology Business Overview Table 92. Jinyu Biotechnology Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio Table 94. Jinyu Biotechnology Recent Development Table 95. Harbin Pharmaceutical Group Bio-vaccine Company Information Table 96. Harbin Pharmaceutical Group Bio-vaccine Business Overview Table 97. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio Table 99. Harbin Pharmaceutical Group Bio-vaccine Recent Development Table 100. DHN Company Information Table 101. DHN Business Overview Table 102. DHN Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. DHN Swine Inactive Vaccine Product Portfolio Table 104. DHN Recent Development Table 105. Boehringer Ingelheim Company Information Table 106. Boehringer Ingelheim Business Overview Table 107. Boehringer Ingelheim Swine Inactive Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio Table 109. Boehringer Ingelheim Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Swine Inactive Vaccine Distributors List Table 113. Swine Inactive Vaccine Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Swine Inactive Vaccine Product Image Figure 2. Global Swine Inactive Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Swine Inactive Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Swine Inactive Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Swine Inactive Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Haemophilus Parasuis Vaccine Image Figure 10. Porcine Circovirus Type 2 Vaccine Image Figure 11. Mycoplasma Hyopneumoniae Bacterin Vaccine Image Figure 12. Others Image Figure 13. Global Swine Inactive Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Swine Inactive Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Inactive Vaccine Sales Volume Share by Type (2021-2032) Figure 16. Global Swine Inactive Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Swine Inactive Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Swine Inactive Vaccine Sales Value Share by Type (2021-2032) Figure 19. Breeding Farm Image Figure 20. Veterinary Clinic Image Figure 21. Global Swine Inactive Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Swine Inactive Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Swine Inactive Vaccine Sales Volume Share by Application (2021-2032) Figure 24. Global Swine Inactive Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Swine Inactive Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Swine Inactive Vaccine Sales Value Share by Application (2021-2032) Figure 27. Global Swine Inactive Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Swine Inactive Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Swine Inactive Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Swine Inactive Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Swine Inactive Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Swine Inactive Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Swine Inactive Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Swine Inactive Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Swine Inactive Vaccine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Swine Inactive Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Swine Inactive Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Swine Inactive Vaccine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Swine Inactive Vaccine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Haemophilus Parasuis Vaccine
  • Porcine Circovirus Type 2 Vaccine
  • Mycoplasma Hyopneumoniae Bacterin Vaccine
  • Others
Applications
  • Breeding Farm
  • Veterinary Clinic
Companies covered
  • Zhongmu Industry
  • Wuhan Keqian Biology
  • Shenzhen BIOCBD Biotechnology
  • Shenlian Biomedical
  • Qindao Lijian Bio-Tech
  • Jinyu Biotechnology
  • Harbin Pharmaceutical Group Bio-vaccine
  • DHN
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Swine Inactive Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Swine Inactive Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Swine Inactive Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Swine Inactive Vaccine Market Dynamics
  1. 2.1 Swine Inactive Vaccine Industry Trends
  2. 2.2 Swine Inactive Vaccine Industry Drivers
  3. 2.3 Swine Inactive Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Inactive Vaccine Industry Restraints
3 Swine Inactive Vaccine Market by Company
  1. 3.1 Global Swine Inactive Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Swine Inactive Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Swine Inactive Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Swine Inactive Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Swine Inactive Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Swine Inactive Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Swine Inactive Vaccine Company Product Type and Application
  8. 3.8 Global Swine Inactive Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Swine Inactive Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Swine Inactive Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Swine Inactive Vaccine Market by Type
  1. 4.1 Swine Inactive Vaccine Type Introduction
  2. 4.1.1 Haemophilus Parasuis Vaccine
  3. 4.1.2 Porcine Circovirus Type 2 Vaccine
  4. 4.1.3 Mycoplasma Hyopneumoniae Bacterin Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Swine Inactive Vaccine Sales Volume by Type
  7. 4.2.1 Global Swine Inactive Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Swine Inactive Vaccine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Swine Inactive Vaccine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Swine Inactive Vaccine Sales Value by Type
  11. 4.3.1 Global Swine Inactive Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Swine Inactive Vaccine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Swine Inactive Vaccine Sales Value Share by Type (2021-2032)
5 Swine Inactive Vaccine Market by Application
  1. 5.1 Swine Inactive Vaccine Application Introduction
  2. 5.1.1 Breeding Farm
  3. 5.1.2 Veterinary Clinic
  4. 5.2 Global Swine Inactive Vaccine Sales Volume by Application
  5. 5.2.1 Global Swine Inactive Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Swine Inactive Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Swine Inactive Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Swine Inactive Vaccine Sales Value by Application
  9. 5.3.1 Global Swine Inactive Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Swine Inactive Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Swine Inactive Vaccine Sales Value Share by Application (2021-2032)
6 Swine Inactive Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Swine Inactive Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Inactive Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Inactive Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Swine Inactive Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Swine Inactive Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Swine Inactive Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Swine Inactive Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Swine Inactive Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Swine Inactive Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Swine Inactive Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Swine Inactive Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Swine Inactive Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Swine Inactive Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Swine Inactive Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Swine Inactive Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Swine Inactive Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Swine Inactive Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Swine Inactive Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Swine Inactive Vaccine Sales Value Share by Country, 2025 VS 2032
7 Swine Inactive Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Swine Inactive Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Swine Inactive Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Swine Inactive Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Swine Inactive Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Swine Inactive Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Swine Inactive Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Swine Inactive Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Swine Inactive Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Swine Inactive Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Swine Inactive Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Swine Inactive Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongmu Industry
  2. 8.1.1 Zhongmu Industry Company Information
  3. 8.1.2 Zhongmu Industry Business Overview
  4. 8.1.3 Zhongmu Industry Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhongmu Industry Swine Inactive Vaccine Product Portfolio
  6. 8.1.5 Zhongmu Industry Recent Developments
  7. 8.2 Wuhan Keqian Biology
  8. 8.2.1 Wuhan Keqian Biology Company Information
  9. 8.2.2 Wuhan Keqian Biology Business Overview
  10. 8.2.3 Wuhan Keqian Biology Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Wuhan Keqian Biology Swine Inactive Vaccine Product Portfolio
  12. 8.2.5 Wuhan Keqian Biology Recent Developments
  13. 8.3 Shenzhen BIOCBD Biotechnology
  14. 8.3.1 Shenzhen BIOCBD Biotechnology Company Information
  15. 8.3.2 Shenzhen BIOCBD Biotechnology Business Overview
  16. 8.3.3 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen BIOCBD Biotechnology Swine Inactive Vaccine Product Portfolio
  18. 8.3.5 Shenzhen BIOCBD Biotechnology Recent Developments
  19. 8.4 Shenlian Biomedical
  20. 8.4.1 Shenlian Biomedical Company Information
  21. 8.4.2 Shenlian Biomedical Business Overview
  22. 8.4.3 Shenlian Biomedical Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shenlian Biomedical Swine Inactive Vaccine Product Portfolio
  24. 8.4.5 Shenlian Biomedical Recent Developments
  25. 8.5 Qindao Lijian Bio-Tech
  26. 8.5.1 Qindao Lijian Bio-Tech Company Information
  27. 8.5.2 Qindao Lijian Bio-Tech Business Overview
  28. 8.5.3 Qindao Lijian Bio-Tech Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qindao Lijian Bio-Tech Swine Inactive Vaccine Product Portfolio
  30. 8.5.5 Qindao Lijian Bio-Tech Recent Developments
  31. 8.6 Jinyu Biotechnology
  32. 8.6.1 Jinyu Biotechnology Company Information
  33. 8.6.2 Jinyu Biotechnology Business Overview
  34. 8.6.3 Jinyu Biotechnology Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jinyu Biotechnology Swine Inactive Vaccine Product Portfolio
  36. 8.6.5 Jinyu Biotechnology Recent Developments
  37. 8.7 Harbin Pharmaceutical Group Bio-vaccine
  38. 8.7.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  39. 8.7.2 Harbin Pharmaceutical Group Bio-vaccine Business Overview
  40. 8.7.3 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Harbin Pharmaceutical Group Bio-vaccine Swine Inactive Vaccine Product Portfolio
  42. 8.7.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments
  43. 8.8 DHN
  44. 8.8.1 DHN Company Information
  45. 8.8.2 DHN Business Overview
  46. 8.8.3 DHN Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 DHN Swine Inactive Vaccine Product Portfolio
  48. 8.8.5 DHN Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Swine Inactive Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Swine Inactive Vaccine Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Inactive Vaccine Value Chain Analysis
  2. 9.1.1 Swine Inactive Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Inactive Vaccine Sales Mode & Process
  6. 9.2 Swine Inactive Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Inactive Vaccine Distributors
  9. 9.2.3 Swine Inactive Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst